Please ensure Javascript is enabled for purposes of website accessibility
Eric Volkman

Eric Volkman

TMFVolkman

Eric has been writing about stocks and finance since the mid-1990s, when he lived in Prague, Czech Republic. Over the course of a varied career, he has also been a radio newscaster, an investment banker, and a bass player in a selection of rock and roll bands. A native New Yorker, he currently lives in Los Angeles.

Recent articles

GettyImages-1290534329

Curaleaf's Q1 Results: Is the CEO Shift a Reason to Buy the Stock?

The newly named CEO displaces a man who will be heading up an intriguing new business unit at the pot company.


Female hand wielding a large pair of scissors

Why Appian Shares Got Slammed On Monday

Although first-quarter results were promising, one researcher has shaved its price target on the company's stock.


Person in a lab looking through a microscope

Why Axsome Therapeutics Stock Got Mashed on Monday

Investors were hardly impressed with the closing of a rights deal.


GettyImages-1055560948

Why DocuSign Stock Got Pummeled Today

An executive resignation spooks nervous investors.


GettyImages-1126114906

Why Tonix Pharmaceuticals Got Crushed Today

Now is not a great time for pre-revenue biotechs to be reporting earnings.

GettyImages-1272017448

Why Intercontinental Exchange Took a Big Hit After Q1 Results

The New York Stock Exchange's owner is opening its wallet for a new acquisition.


GettyImages-1294843884

Why Hexo Stock Wilted So Badly This Week

A dilutive new share issue and negative sentiment about pot stocks generally combine for a double-digit share price dip.


GettyImages-1290287566

Why Blue Apron Was a Tasty Stock This Week

The meal kit specialist delivered a box of good news about its finances.


Young woman at a desk using a PC and tablet computer simultaneously

Why Appian Stock Topped the Market Today

There's nothing like a pair of quarterly beats to make shareholders happy.


GettyImages-1287152859

Why DoorDash Stock Flopped on Friday

The company beat expectations on first-quarter revenue, but whiffed on the bottom line.

0x0-Model3_03

Why Tesla Stock Was Slumping on Friday

The electric vehicle powerhouse might, or might not, be cranking up production at its Shanghai gigafactory.


GettyImages-621987840

Why Revolve Group Stock Was Down by Over 20% This Week

Counterintuitively, the shares suffered a big drop after the retailer delivered a better-than-expected first quarter.


GettyImages-1169650956

Why DraftKings Stock Was a Good Bet This Week

The company is the proud new owner of a complementary online gambling business.


GettyImages-592647720

Why Clovis Oncology Stock Was Plummeting This Week

Investors bailed from the company after a quarterly results and operational update.


GettyImages-1295286606

Why TripAdvisor Soared High Above the Market Today

The company more than doubled its revenue in the inaugural quarter of 2022.

Two people seated at a lab desk featuring a PC screen and microscope

Why Global Blood Therapeutics Stock Was Sickly Today

The bears pounced on the company despite a first-quarter bottom-line beat.


Woman in a lab looking through a microscope

Why BioCryst Stock Lost Nearly 4% of Its Value Today

The biotech whiffs on both revenue and profitability for its first quarter, and indicates more losses are in store.


GettyImages-174667095

Why Royal Caribbean Got Thrashed on Thursday

The company is indisputably in recovery mode, but it whiffed on first-quarter estimates.


GettyImages-1298319426

Why eBay Stock Tanked Today

Investors weren't pleased with the company's first-quarter results, to put it mildly.


GettyImages-488872074

Teva's Q1 Results: Is the Stock About to Crash?

The company met analyst expectations for revenue and profitability, yet that's not necessarily a good thing.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.